etoposide has been researched along with cyclin d1 in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (61.11) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duquesne, F; Florent, M; Roué, G; Sola, B; Troussard, X | 1 |
| Adachi, S; Han, Z; Obaya, AJ; Ramos-Desimone, N; Sedivy, JM; Wyche, JH | 1 |
| Chen, LL; Huang, HC; Huang, TS; Lee, CC; Lin, S | 1 |
| Kavurma, MM; Khachigian, LM | 1 |
| Parent, AD; Tamaki, N; Yin, D; Zhang, JH | 1 |
| Ahmed, F; Cernak, I; Di Giovanni, S; Faden, AI; Movsesyan, V; Schinelli, S; Stoica, B | 1 |
| Koistinen, P; Savolainen, ER; Siitonen, T | 1 |
| Fukasawa, K; Izumi, M; Kamiyama, J; Kawa, S; Maruyama, S; Nikaido, T; Sakai, T; Sukenaga, Y; Takahara, Y; Wakada, M; Watanabe, N; Yogosawa, S; Yokoyama, H; Yoshizawa, K; Zhang, H | 1 |
| Gotoh, M; Katsu, K; Kawabe, S; Kii, T; Kuwakado, S; Nishitani, H; Ohta, S; Takiuchi, H; Tanaka, T | 1 |
| Ates, H; Pehlivan, M; Sercan, HO; Sercan, Z; Simsek, O | 1 |
| Biegel, JA; Cho, YJ; Evans, JA; Greulich, H; McKenna, ES; Moreau, LA; Pomeroy, SL; Roberts, CW; Sansam, CG; Thom, CS | 1 |
| Aplin, AE; Hu, R | 1 |
| Alluin, JV; Chen, RW; Chomchan, P; Forman, SJ; Gaur, S; Honegger, A; Rossi, JJ; Tiemann, K; Yun, Y | 1 |
| Deng, LJ; Lin, NJ; Liu, WP; Ping, LY; Song, YQ; Tu, MF; Wang, XP; Xie, Y; Ying, ZT; Zhang, C; Zheng, W; Zhu, J | 1 |
| Ahn, MY; Choi, G; Kim, HS; Kim, JH; Kim, WK; Lee, HJ; Lee, YJ; Moon, HR; Yang, Z; Yoon, S | 1 |
| Choudhuri, T; Das, D; Kundu, CN; Mohapatra, P; Preet, R; Satapathy, SR; Wyatt, MD | 1 |
| Chen, J; Chen, Y; He, Q; Li, X; Xu, R | 1 |
| Erbaykent-Tepedelen, B; Gonen-Korkmaz, C; Karamil, S; Korkmaz, KS | 1 |
18 other study(ies) available for etoposide and cyclin d1
| Article | Year |
|---|---|
Ectopic expression of cyclin D1 impairs the proliferation and enhances the apoptosis of a murine lymphoid cell line.
Topics: Animals; Apoptosis; B-Lymphocytes; bcl-2-Associated X Protein; Cell Cycle; Cell Cycle Proteins; Cell Division; Cell Line; Cell Survival; Clone Cells; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Dose-Response Relationship, Drug; Ecdysterone; Etoposide; Genetic Vectors; Interleukin-3; Mice; Nucleic Acid Synthesis Inhibitors; Promoter Regions, Genetic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Stem Cells; Transfection; Tumor Suppressor Protein p53 | 2001 |
c-Myc is necessary for DNA damage-induced apoptosis in the G(2) phase of the cell cycle.
Topics: Adenine; Animals; Apoptosis; CDC2-CDC28 Kinases; Cell Line; Cisplatin; Cross-Linking Reagents; Cyclin A; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; DNA Damage; Enzyme Activation; Enzyme Inhibitors; Etoposide; Flow Cytometry; G1 Phase; G2 Phase; Immunoblotting; Kinetics; Mutagenesis, Site-Directed; Nucleic Acid Synthesis Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-myc; Rats; Recombination, Genetic; Time Factors; Transgenes | 2001 |
GL331 induces down-regulation of cyclin D1 expression via enhanced proteolysis and repressed transcription.
Topics: Antineoplastic Agents, Phytogenic; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Down-Regulation; Etoposide; Gene Expression; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Proto-Oncogene Proteins; RNA, Messenger; Signal Transduction; Transcription, Genetic; Tumor Cells, Cultured | 2001 |
Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4-p21WAF1/Cip1 complex formation.
Topics: Animals; Apoptosis; Arteries; Blotting, Western; Bromodeoxyuridine; CDC2-CDC28 Kinases; Cell Cycle; Cell Division; Cell Line; Cells, Cultured; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Down-Regulation; Endothelium, Vascular; Etoposide; Genes, Dominant; Mutation; Myocytes, Smooth Muscle; Nucleic Acid Synthesis Inhibitors; Oligonucleotides, Antisense; Phosphorylation; Plasmids; Precipitin Tests; Promoter Regions, Genetic; Protein Binding; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Rats; Rats, Inbred WKY; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sp1 Transcription Factor; Time Factors; Transcription, Genetic; Zinc Fingers | 2003 |
Insulin-like growth factor-I decreased etoposide-induced apoptosis in glioma cells by increasing bcl-2 expression and decreasing CPP32 activity.
Topics: Apoptosis; Benzimidazoles; Blotting, Southern; Blotting, Western; Caspase 3; Caspases; Cell Count; Cell Line, Tumor; Cell Proliferation; Colorimetry; Cyclin D1; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Interactions; Endopeptidases; Etoposide; Gene Expression Regulation, Neoplastic; Glioma; Humans; Insulin-Like Growth Factor I; Nerve Tissue Proteins; Nucleic Acid Synthesis Inhibitors; Oligodeoxyribonucleotides, Antisense; Receptor, IGF Type 1; Tetrazolium Salts; Thiazoles; Time Factors; Transfection | 2005 |
Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury.
Topics: Animals; Apoptosis; Astrocytes; Brain Injuries; Caspase 3; Caspases; Cell Cycle; Cell Proliferation; Cell Survival; Cells, Cultured; Cicatrix; Cyclin D1; Cyclin-Dependent Kinases; DNA Damage; Etoposide; Flavonoids; Gene Expression Regulation; Male; Neuroglia; Neuroprotective Agents; Piperidines; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley | 2005 |
Increase in Ara-C cytotoxicity in the presence of valproate, a histone deacetylase inhibitor, is associated with the concurrent expression of cyclin D1 and p27(Kip 1) in acute myeloblastic leukemia cells.
Topics: Butyrates; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Cytarabine; Enzyme Inhibitors; Etoposide; Histone Deacetylase Inhibitors; Humans; Leukemia, Myeloid, Acute; Valproic Acid | 2005 |
Lysocellin, a metabolite of the novel drug 'alopestatin', induces G1 arrest and prevents cytotoxicity induced by etoposide.
Topics: Alopecia; Animals; Animals, Newborn; Antineoplastic Agents, Phytogenic; Area Under Curve; Blotting, Northern; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Down-Regulation; Etoposide; Female; Furans; G1 Phase; Gene Expression; Humans; Male; Osteosarcoma; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Up-Regulation | 2006 |
Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemoradiotherapy using biopsy specimens.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclin D1; Cyclophosphamide; Doxorubicin; ErbB Receptors; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Male; Prognosis; Proliferating Cell Nuclear Antigen; Tumor Suppressor Protein p53 | 2007 |
Induction of apoptosis increases expression of non-canonical WNT genes in myeloid leukemia cell lines.
Topics: Antineoplastic Agents; Benzamides; Caspase 3; Cell Line, Tumor; Cyclin D1; Etoposide; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Piperazines; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Wnt Proteins | 2007 |
Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability.
Topics: Animals; Cell Line, Tumor; Chromosomal Proteins, Non-Histone; Cisplatin; Cyclin D1; Diploidy; DNA Damage; DNA Repair; DNA-Binding Proteins; Epigenesis, Genetic; Etoposide; G2 Phase; Genomic Instability; Histones; Humans; Mice; Neoplasms; Phenotype; Polymorphism, Single Nucleotide; Protein Transport; Rhabdoid Tumor; SMARCB1 Protein; Transcription Factors | 2008 |
alphaB-crystallin is mutant B-RAF regulated and contributes to cyclin D1 turnover in melanocytic cells.
Topics: alpha-Crystallin B Chain; Bleomycin; Butadienes; Cells, Cultured; Cyclin D1; Cycloheximide; DNA Damage; Etoposide; Humans; Leupeptins; Melanocytes; Melanoma; Mutant Proteins; Mutation; Nitriles; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Structure-Activity Relationship; Tetracycline | 2010 |
Small interfering RNAs targeting cyclin D1 and cyclin D2 enhance the cytotoxicity of chemotherapeutic agents in mantle cell lymphoma cell lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin D2; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Etoposide; Humans; Immunoblotting; Inhibitory Concentration 50; Lymphoma, Mantle-Cell; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference | 2011 |
The clinical features, therapeutic responses, and prognosis of the patients with mantle cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclin D1; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Prednisone; Remission Induction; Rituximab; Stem Cell Transplantation; Survival Rate; Vincristine | 2012 |
A novel carbazole derivative, MHY407, sensitizes cancer cells to doxorubicin-, etoposide-, and radiation treatment via DNA damage.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carbazoles; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Epoxy Compounds; Etoposide; Female; G1 Phase Cell Cycle Checkpoints; Humans; MCF-7 Cells; Neoplasms; Radiation-Sensitizing Agents; S Phase Cell Cycle Checkpoints; Time Factors | 2012 |
Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
Topics: Adenomatous Polyposis Coli Protein; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Blotting, Western; Breast Neoplasms; Carotenoids; Cell Cycle; Cell Proliferation; Comet Assay; Cyclin D1; Drug Synergism; Etoposide; Female; Flow Cytometry; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lycopene; Promoter Regions, Genetic; Quinacrine; RNA, Small Interfering; Signal Transduction; T Cell Transcription Factor 1; TCF Transcription Factors; Trans-Activators; Transcription, Genetic; Tumor Cells, Cultured; Tumor Stem Cell Assay; Wnt Proteins | 2013 |
Cleavage of bleomycin hydrolase by caspase-3 during apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Bleomycin; Caspase 3; Caspase 9; Caspase Inhibitors; Cell Line, Tumor; Cyclin D1; Cysteine Endopeptidases; Etoposide; HeLa Cells; Humans; Hydrolysis | 2013 |
DNA damage response (DDR) via NKX3.1 expression in prostate cells.
Topics: Acid Anhydride Hydrolases; Ataxia Telangiectasia Mutated Proteins; Camptothecin; Cell Cycle; Cell Line, Tumor; Cyclin D1; DNA Damage; DNA Repair; DNA Repair Enzymes; DNA-Activated Protein Kinase; DNA-Binding Proteins; Doxorubicin; Etoposide; Histones; Homeodomain Proteins; Humans; Hydrogen Peroxide; Irinotecan; Male; Metribolone; Mutagens; Phosphorylation; Prostatic Neoplasms; Protein Processing, Post-Translational; Testosterone Congeners; Transcription Factors | 2014 |